MOTS-c — a mitochondrial peptide in metabolic research

MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) is a short, 16-amino-acid peptide belonging to the family of mitochondrial-derived peptides (MDP, mitochondrial-derived peptides). Its sequence is encoded not in the nuclear genome, but within the mitochondrial 12S rRNA gene — which makes MOTS-c one of the few known peptides written directly in the mitochondrial DNA. If peptides are treated as "protein fragments" and one of the languages through which cells communicate, then MOTS-c is a particularly interesting word: it originates from an organelle traditionally regarded solely as the cell's "power plant." It is precisely this feature that has made it the subject of intensive preclinical research — as a potential signaling molecule linking mitochondrial metabolism with gene expression in the nucleus.

Mechanism in brief

Unlike classical peptide hormones, in the literature MOTS-c does not have an unambiguously identified, specific membrane receptor operating on a "lock-and-key" principle. Preclinical studies describe it rather as an intracellular signaling molecule. Under metabolic stress, MOTS-c translocates to the cell nucleus, where — in cellular models — it is associated with regulating the expression of stress-response genes, including in connection with the AMPK pathway and transcription factors of the Nrf2 family. This direction of communication, from mitochondrion to nucleus, is sometimes referred to in the literature as mitochondrial-to-nuclear (retrograde) signaling.

What is being studied

The scope of scientific interest concerns mechanisms observed in laboratory models, not effects in humans. Four areas recur in the preclinical literature:

• Metabolic homeostasis and glucose metabolism — animal models. In mouse models (including high-fat diet), MOTS-c has been studied in the context of regulating glucose handling and tissue insulin sensitivity, with a connection to the AMPK pathway. These are observations in animals that require further research.
• Mitochondrial-to-nuclear signaling — in vitro / cell lines. In cell cultures, translocation of the peptide to the nucleus and its participation in regulating transcriptional programs activated by metabolic stress have been described.
• Metabolic stress response — animal models and in vitro. MOTS-c has been analyzed in the context of the folate cycle, AICAR metabolism and de novo purine biosynthesis — as possible nodes through which the peptide influences AMPK activation.
• Energy pathways and ATP production — cellular studies. The role of MOTS-c in the cell's energy balance and substrate utilization has been considered, as an element of the intracellular response to an energy deficit.

In biohacking culture and in search queries, MOTS-c is sometimes described with the colloquial catchphrase "exercise in a vial". This is solely a cultural/marketing label and a search term — not a description of a proven action and not a promise of any effect.

Origin and historical context

MOTS-c was characterized in 2015 in a paper published in the journal Cell Metabolism (Lee et al.). Research on mitochondrial-derived peptides was conducted, among others, in the laboratory of Prof. Pinchas Cohen at the University of Southern California (USC). MOTS-c then joined the previously described MDP family, which also includes humanin — the first characterized peptide of this type. The discovery was part of a broader shift in the view of mitochondria: from a purely energetic organelle toward a source of signaling molecules participating in communication with the rest of the cell. It is precisely this context — and not any health application — that keeps MOTS-c within the area of active preclinical research.

Research specification

In research supply, MOTS-c most often occurs in the form of a lyophilisate (powder after lyophilization), which favors the material's stability for laboratory applications. Storage is discussed solely in the context of research work — cool, away from light and moisture, in accordance with the practice for peptides. The quality standard for research material is purity verification by the HPLC method and confirmation of the compound's identity; these parameters, together with the batch number, are described in the certificate of analysis (COA). Details concerning a given substance can be found in the safety data sheet section. The above concerns the quality and identification of the material and does not declare any health properties.

Level of evidence

According to the current state of knowledge, evidence regarding MOTS-c comes primarily from in vitro studies (cell lines) and animal models (mainly murine). Limited observational data in humans are available — e.g. measurements of circulating peptide concentration in various metabolic states — whereas conclusive, controlled interventional studies in humans have in practice not been published or are very few. This means that mechanistic conclusions do not automatically transfer to humans, and the entire area requires further research. MOTS-c remains primarily a tool and a subject of basic research on mitochondrial signaling.

For research purposes only. Not for human or animal consumption.